高盛-信达生物(1801.HK):一季度产品销售额超预期,IBI363IBI3032为ASCOADA会议首要关注焦点,给予买入评级-Innovent Biologics(1801.HK):1Q product sales beat;IBI363IBI3032 as top focus for ASCOADA;Buy-20260501【8页】

发表回复

后才能评论